Strategies for Biologic Image-Guided Dose Escalation: A Review

International Journal of Radiation Oncology Biology Physics

Volumn 73, Issue 3, 2009, Pages 650-658

  Søvik, Åste ^a   Malinen, Eirik ^a   Olsen, Dag Rune ^a,b  

^a OSLO UNIVERSITY HOSPITAL   (Norway)

^b UNIVERSITY OF OSLO   (Norway)

Author keywords

Image guidance; IMRT; MR; PET; Radiotherapy

Indexed keywords

PHYSICAL THERAPY; PLANNING; POSITRON EMISSION TOMOGRAPHY; RADIOTHERAPY; STRATEGIC PLANNING; THREE DIMENSIONAL;

CLINICAL PRACTICES; CURRENT STATUS; DOSE ESCALATIONS; IMAGE GUIDANCE; IMAGE-BASED; IMAGE-GUIDED; IMAGING MODALITIES; IMRT; INTENSITY-MODULATED RADIATION THERAPIES; MOLECULAR INFORMATIONS; MR; OPTIMAL TREATMENTS; PET; RADIATION DOSE; TARGET VOLUME DELINEATIONS; TREATMENT PLANS; TUMOR IMAGING;

PATIENT TREATMENT;

1 FLUORO 3 (2 NITRO 1 IMIDAZOLYL) 2 PROPANOL F 18; FLUORODEOXYGLUCOSE F 18;

CLINICAL PRACTICE; EXTERNAL BEAM RADIOTHERAPY; HEALTH CARE DELIVERY; IMAGING; INTENSITY MODULATED RADIATION THERAPY; MONITORING; PRIORITY JOURNAL; RADIATION DOSE; REVIEW; TREATMENT OUTCOME; TREATMENT PLANNING; TREATMENT RESPONSE;

CELL HYPOXIA; FLUORODEOXYGLUCOSE F18; HUMANS; MAGNETIC RESONANCE IMAGING; NEOPLASMS; POSITRON-EMISSION TOMOGRAPHY; RADIATION TOLERANCE; RADIOPHARMACEUTICALS; RADIOTHERAPY DOSAGE; RADIOTHERAPY, INTENSITY-MODULATED; TOMOGRAPHY, X-RAY COMPUTED; TREATMENT OUTCOME; TUMOR BURDEN;

EID: 59649100572     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2008.11.001     Document Type: Review

References (65)

1. Laskar S.G., Agarwal J.P., Srinivas C., et al. Radiotherapeutic management of locally advanced head and neck cancer. Expert Rev Anticancer Ther 6 (2006) 405-417
2. Chao K.S., Ozyigit G., Tran B.N., et al. Patterns of failure in patients receiving definitive and postoperative IMRT for head-and-neck cancer. Int J Radiat Oncol Biol Phys 55 (2003) 312-321
3. Cellini N., Morganti A.G., Mattiucci G.C., et al. Analysis of intraprostatic failures in patients treated with hormonal therapy and radiotherapy: Implications for conformal therapy planning. Int J Radiat Oncol Biol Phys 53 (2002) 595-599
4. Ling C.C., Humm J., Larson S., et al. Towards multidimensional radiotherapy (MD-CRT): Biological imaging and biological conformality. Int J Radiat Oncol Biol Phys 47 (2000) 551-360
5. Bentzen S.M. Theragnostic imaging for radiation oncology: Dose-painting by numbers. Lancet Oncol 6 (2005) 112-117
6. Yang Y., and Xing L. Towards biologically conformal radiation therapy (BCRT): Selective IMRT dose escalation under the guidance of spatial biology distribution. Med Phys 32 (2005) 1473-1484
7. Sovik A., Malinen E., Skogmo H.K., et al. Radiotherapy adapted to spatial and temporal variability in tumor hypoxia. Int J Radiat Oncol Biol Phys 68 (2007) 1496-1504
8. Galvin J.M., and De N.W. Intensity modulating and other radiation therapy devices for dose painting. J Clin Oncol 25 (2007) 924-930
9. Chapman J.D., Bradley J.D., Eary J.F., et al. Molecular (functional) imaging for radiotherapy applications: an RTOG symposium. Int J Radiat Oncol Biol Phys 55 (2003) 294-301
10. Chao K.S., Bosch W.R., Mutic S., et al. A novel approach to overcome hypoxic tumor resistance: Cu-ATSM-guided intensity-modulated radiation therapy. Int J Radiat Oncol Biol Phys 49 (2001) 1171-1182
11. Alber M., Paulsen F., Eschmann S.M., et al. On biologically conformal boost dose optimization. Phys Med Biol 48 (2003) N31-N35
12. Solberg T.D., Agazaryan N., Goss B.W., et al. A feasibility study of 18F-fluorodeoxyglucose positron emission tomography targeting and simultaneous integrated boost for intensity-modulated radiosurgery and radiotherapy. J Neurosurg 101 Suppl 3 (2004) 381-389
13. Das S.K., Miften M.M., Zhou S., et al. Feasibility of optimizing the dose distribution in lung tumors using fluorine-18-fluorodeoxyglucose positron emission tomography and single photon emission computed tomography guided dose prescriptions. Med Phys 31 (2004) 1452-1461
14. van Lin E.N., Futterer J.J., Heijmink S.W., et al. IMRT boost dose planning on dominant intraprostatic lesions: Gold marker-based three-dimensional fusion of CT with dynamic contrast-enhanced and 1H-spectroscopic MRI. Int J Radiat Oncol Biol Phys 65 (2006) 291-303
15. Vanderstraeten B., Duthoy W., Gersem W.D., et al. [(18)F]fluoro-deoxy-glucose positron emission tomography ([(18)F]FDG-PET) voxel intensity-based intensity-modulated radiation therapy (IMRT) for head and neck cancer. Radiother Oncol 79 (2006) 249-258
16. Thorwarth D., Eschmann S.M., Paulsen F., et al. Hypoxia dose painting by numbers: A planning study. Int J Radiat Oncol Biol Phys 68 (2007) 291-300
17. Madani I., Duthoy W., Derie C., et al. Positron emission tomography-guided, focal-dose escalation using intensity-modulated radiotherapy for head and neck cancer. Int J Radiat Oncol Biol Phys 68 (2007) 126-135
18. Chen G.P., Ahunbay E., Schultz C., et al. Development of an inverse optimization package to plan nonuniform dose distributions based on spatially inhomogeneous radiosensitivity extracted from biological images. Med Phys 34 (2007) 1198-1205
19. Grosu A.L., Souvatzoglou M., Roper B., et al. Hypoxia imaging with FAZA-PET and theoretical considerations with regard to dose painting for individualization of radiotherapy in patients with head and neck cancer. Int J Radiat Oncol Biol Phys 69 (2007) 541-551
20. Lee N.Y., Mechalakos J.G., Nehmeh S., et al. Fluorine-18-labeled fluoromisonidazole positron emission and computed tomography-guided intensity-modulated radiotherapy for head and neck cancer: A feasibility study. Int J Radiat Oncol Biol Phys 70 (2008) 2-13
21. Grosu A.L., Piert M., Weber W.A., et al. Positron emission tomography for radiation treatment planning. Strahlenther Onkol 181 (2005) 483-499
22. Zhao S., Kuge Y., Mochizuki T., et al. Biologic correlates of intratumoral heterogeneity in 18F-FDG distribution with regional expression of glucose transporters and hexokinase-II in experimental tumor. J Nucl Med 46 (2005) 675-682
23. Vesselle H., Schmidt R.A., Pugsley J.M., et al. Lung cancer proliferation correlates with [F-18]fluorodeoxyglucose uptake by positron emission tomography. Clin Cancer Res 6 (2000) 3837-3844
24. Dimitrakopoulou-Strauss A., Strauss L.G., Schwarzbach M., et al. Dynamic PET 18F-FDG studies in patients with primary and recurrent soft-tissue sarcomas: Impact on diagnosis and correlation with grading. J Nucl Med 42 (2001) 713-720
25. Buck A., Schirrmeister H., Kuhn T., et al. FDG uptake in breast cancer: Correlation with biological and clinical prognostic parameters. Eur J Nucl Med Mol Imaging 29 (2002) 1317-1323
26. Allal A.S., Slosman D.O., Kebdani T., et al. Prediction of outcome in head-and-neck cancer patients using the standardized uptake value of 2-[18F]fluoro-2-deoxy-D-glucose. Int J Radiat Oncol Biol Phys 59 (2004) 1295-1300
27. Kim S.Y., Roh J.L., Kim M.R., et al. Use of 18F-FDG PET for primary treatment strategy in patients with squamous cell carcinoma of the oropharynx. J Nucl Med 48 (2007) 752-757
28. Kostakoglu L., Agress Jr. H., and Goldsmith S.J. Clinical role of FDG PET in evaluation of cancer patients. Radiographics 23 (2003) 315-340
29. Gray L.H., Conger A.D., Ebert M., et al. The concentration of oxygen dissolved in tissues at the time of irradiation as a factor in radiotherapy. Br J Radiol 26 (1953) 638-648
30. Sundfor K., Lyng H., Trope C.G., et al. Treatment outcome in advanced squamous cell carcinoma of the uterine cervix: Relationships to pretreatment tumor oxygenation and vascularization. Radiother Oncol 54 (2000) 101-107
31. Movsas B., Chapman J.D., Hanlon A.L., et al. Hypoxic prostate/muscle pO2 ratio predicts for biochemical failure in patients with prostate cancer: Preliminary findings. Urology 60 (2002) 634-639
32. Nordsmark M., Bentzen S.M., Rudat V., et al. Prognostic value of tumor oxygenation in 397 head and neck tumors after primary radiation therapy. An international multi-center study. Radiother Oncol 77 (2005) 18-24
33. Suzuki Y., Nakano T., Ohno T., et al. Oxygenated and reoxygenated tumors show better local control in radiation therapy for cervical cancer. Int J Gynecol Cancer 16 (2006) 306-311
34. Rajendran J.G., Hendrickson K.R., Spence A.M., et al. Hypoxia imaging-directed radiation treatment planning. Eur J Nucl Med Mol Imaging 33 Suppl 1 (2006) 44-53
35. Eschmann S.M., Paulsen F., Reimold M., et al. Prognostic impact of hypoxia imaging with 18F-misonidazole PET in non-small cell lung cancer and head and neck cancer before radiotherapy. J Nucl Med 46 (2005) 253-260
36. Rajendran J.G., Schwartz D.L., O'Sullivan J., et al. Tumor hypoxia imaging with [F-18] fluoromisonidazole positron emission tomography in head and neck cancer. Clin Cancer Res 12 (2006) 5435-5441
37. Cooper R.A., Carrington B.M., Loncaster J.A., et al. Tumour oxygenation levels correlate with dynamic contrast-enhanced magnetic resonance imaging parameters in carcinoma of the cervix. Radiother Oncol 57 (2000) 53-59
38. Zahra M.A., Hollingsworth K.G., Sala E., et al. Dynamic contrast-enhanced MRI as a predictor of tumour response to radiotherapy. Lancet Oncol 8 (2007) 63-74
39. Costello L.C., Franklin R.B., and Narayan P. Citrate in the diagnosis of prostate cancer. Prostate 38 (1999) 237-245
40. Zakian K.L., Sircar K., Hricak H., et al. Correlation of proton MR spectroscopic imaging with Gleason score based on step-section pathologic analysis after radical prostatectomy. Radiology 234 (2005) 804-814
41. Speight J.L., and Roach III M. Advances in the treatment of localized prostate cancer: The role of anatomic and functional imaging in men managed with radiotherapy. J Clin Oncol 25 (2007) 987-995
42. Tofts P.S. Modeling tracer kinetics in dynamic Gd-DTPA MR imaging. J Magn Reson Imaging 7 (1997) 91-101
43. Weber W.A. Use of PET for monitoring cancer therapy and for predicting outcome. J Nucl Med 46 (2005) 983-995
44. Thorwarth D., Eschmann S.M., Paulsen F., et al. A kinetic model for dynamic [18F]-Fmiso PET data to analyse tumour hypoxia. Phys Med Biol 50 (2005) 2209-2224
45. Thorwarth D., Eschmann S.M., Scheiderbauer J., et al. Kinetic analysis of dynamic 18F-fluoromisonidazole PET correlates with radiation treatment outcome in head-and-neck cancer. BMC Cancer 5 (2005) 152
46. Roe K., Muren L.P., Rorvik J., et al. Dynamic contrast enhanced magnetic resonance imaging of bladder cancer and implications for biological image-adapted radiotherapy. Acta Oncol 47 (2008) 1257-1264
47. Busk M., Horsman M.R., and Overgaard J. Resolution in PET hypoxia imaging: voxel size matters. Acta Oncol 47 (2008) 1201-1210
48. Sumanaweera T.S., Glover G.H., Binford T.O., et al. MR susceptibility misregistration correction. IEEE Trans Med Imaging 12 (1993) 251-259
49. Malinen E., Sovik A., Hristov D., et al. Adapting radiotherapy to hypoxic tumours. Phys Med Biol 51 (2006) 4903-4921
50. Zhang P., Osterman K.S., Liu T., et al. How does performance of ultrasound tissue typing affect design of prostate IMRT dose-painting protocols?. Int J Radiat Oncol Biol Phys 67 (2007) 362-368
51. Balter J.M., and Kessler M.L. Imaging and alignment for image-guided radiation therapy. J Clin Oncol 25 (2007) 931-937
52. Park S.J., Ionascu D., Killoran J., et al. Evaluation of the combined effects of target size, respiratory motion and background activity on 3D and 4D PET/CT images. Phys Med Biol 53 (2008) 3661-3679
53. Nahum A.E., and Sanchez-Nieto B. Tumor control probability modelling: Basic principles and applications in treatment planning. Phys Med XVII Suppl 2 (2001) 13-23
54. Niemierko A. Reporting and analyzing dose distributions: A concept of equivalent uniform dose. Med Phys 24 (1997) 103-110
55. Brahme A., and Agren A.K. Optimal dose distribution for eradication of heterogeneous tumours. Acta Oncol 26 (1987) 377-385
56. Hall E.J., and Giaccia A.J. Oxgen effect and reoxygenation. In: Hall E.J., and Giaccia A.J. (Eds). Radiobiology for the radiologist (2006), Lippincott Williams & Wilkins, Philadelphia 85-105
57. Wang J.Z., Li X.A., and Mayr N.A. Dose escalation to combat hypoxia in prostate cancer: A radiobiological study on clinical data. Br J Radiol 79 (2006) 905-911
58. Sovik A., Malinen E., Bruland O.S., et al. Optimization of tumor control probability in hypoxic tumors by radiation dose redistribution: A modelling study. Phys Med Biol 52 (2007) 499-513
59. Flynn R.T., Barbee D.L., Mackie T.R., et al. Comparison of intensity modulated x-ray therapy and intensity modulated proton therapy for selective subvolume boosting: A phantom study. Phys Med Biol 52 (2007) 6073-6091
60. Schaly B., Kempe J.A., Bauman G.S., et al. Tracking the dose distribution in radiation therapy by accounting for variable anatomy. Phys Med Biol 49 (2004) 791-805
61. Thorwarth D., Eschmann S.M., Paulsen F., et al. A model of reoxygenation dynamics of head-and-neck tumors based on serial 18F-fluoromisonidazole positron emission tomography investigations. Int J Radiat Oncol Biol Phys 68 (2007) 515-521
62. Strauss L.G. Fluorine-18 deoxyglucose and false-positive results: A major problem in the diagnostics of oncological patients. Eur J Nucl Med 23 (1996) 1409-1415
63. Sovik A., Kippenes S.H., Bruland O.S., et al. DCEMRI monitoring of canine tumors during fractionated radiotherapy. Acta Oncol 47 (2008) 1249-1256
64. Hicks R.J., Rischin D., Fisher R., et al. Utility of FMISO PET in advanced head and neck cancer treated with chemoradiation incorporating a hypoxia-targeting chemotherapy agent. Eur J Nucl Med Mol Imaging 32 (2005) 1384-1391
65. Nakano T., Suzuki Y., Ohno T., et al. Carbon beam therapy overcomes the radiation resistance of uterine cervical cancer originating from hypoxia. Clin Cancer Res 12 (2006) 2185-2190